There is growing evidence that women with thrombophilia are at increased risk of pregnancy
related venous thromboembolism and of adverse pregnancy outcome including pregnancy …

FACTOR V LEIDEN IS A COMMON GENETIC MUTATION that predisposes its carriers to
venous thromboembolism. When combined with the hypercoagulable state that is …

The magnitude of the association of factor V Leiden mutation with pregnancy-related venous
thrombosis remains unclear. Our objective was to undertake a systematic review and a meta …

Factor V Leiden is a common gain-of-function gene mutation resulting in a genetic
predisposition to thromboembolic complications. Growing evidence in the literature indicates …

BACKGROUND AND OBJECTIVES: In this retrospective, single center, cohort study we
assessed the risk of pregnancy-related venous thromboembolism (VTE) in women …

The conclusions of studies to date which evaluate a possible association between factor V
Leiden and adverse pregnancy outcome have been conflicting. This study was undertaken …

ABSTRACT Factor V Leiden (FVL) is a newly discovered genetic mutation that impairs one
of the body's naturally occurring anticoagulation systems. The result is resistance to …

OBJECTIVE: To assess the rate of early (first trimester) and late (second and third trimester)
fetal loss in women who are factor V Leiden homozygous. METHODS: Between December …

The risk of venous thromboembolism (VTE) is increased in pregnancy and during the post‐
partum period. The absolute risk for pregnancy‐related VTE in heterozygous women with …

Normal maternal adaptation to pregnancy significantly increases the risk for thrombus
formation. Inherited thrombophilias further increase risk for deep venous thrombosis and …